Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 46 (RPL31P46)

Target
RPL31P46
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L31 pseudogene 46 (RPL31P46) is a processed pseudogene located on chromosome 11 (GRCh38:CM000673.2), specifically at 74,919,587-74,919,965 on the forward strand[2]. It is a genomic fragment derived from the functional RPL31 gene, which encodes a component of the 60S ribosomal subunit involved in protein synthesis[7][3]. Pseudogenes like RPL31P46 are typically non-functional, result from retrotransposition events, and are distributed throughout the human genome[5]. While ribosomal protein pseudogenes may act as evolutionary markers or—much more rarely—have regulatory effects, RPL31P46 does not encode a functional protein and has no recognized biological or disease role[2][5][8].\n\nIn summary, RPL31P46 (Ribosomal protein L31 pseudogene 46) is a non-functional pseudogene and not a therapeutic target, receptor, enzyme, transporter, nor used in drug discovery or clinical biomarker applications[2][5][8].

Other names
RPL31_23_1157RPL31P46
02

Mechanism of action

None; pseudogenes do not encode protein, thus no drug mechanism is applicable

03

Biological functions

None (pseudogenes generally do not have biological function unless evidence of regulatory activity exists)
04

Disease associations

None for RPL31P46 directly. The functional RPL31 gene is associated with conditions like Diamond-Blackfan anemia, but the pseudogene is not involved therapeutically.
05

Safety considerations

None; pseudogenes have no direct safety or therapeutic relevance
06

Interacting drugs

None
07

Biomarkers

None known for RPL31P46. Some ribosomal proteins or processed pseudogenes can be used in research as evolutionary or genomic markers but not clinically

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 46 (RPL31P46).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 46 (RPL31P46).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call